Morgan Stanley’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Buy |
63,331
+30,523
| +93% | +$51.6K | ﹤0.01% | 6102 |
|
|
2025
Q1 | $66.9K | Sell |
32,808
-4,000
| -11% | -$8.16K | ﹤0.01% | 6176 |
|
|
2024
Q4 | $121K | Buy |
36,808
+2,600
| +8% | +$8.55K | ﹤0.01% | 5979 |
|
|
2024
Q3 | $94.1K | Buy |
34,208
+4,390
| +15% | +$12.1K | ﹤0.01% | 6033 |
|
|
2024
Q2 | $121K | Buy |
29,818
+3,000
| +11% | +$12.2K | ﹤0.01% | 5893 |
|
|
2024
Q1 | $179K | Sell |
26,818
-7,618
| -22% | -$51K | ﹤0.01% | 5771 |
|
|
2023
Q4 | $162K | Buy |
34,436
+19,874
| +136% | +$93.4K | ﹤0.01% | 6025 |
|
|
2023
Q3 | $60.7K | Sell |
14,562
-722
| -5% | -$3.01K | ﹤0.01% | 6083 |
|
|
2023
Q2 | $48.1K | Buy |
15,284
+733
| +5% | +$2.31K | ﹤0.01% | 6227 |
|
|
2023
Q1 | $64.6K | Buy |
14,551
+758
| +5% | +$3.37K | ﹤0.01% | 6191 |
|
|
2022
Q4 | $91.3K | Sell |
13,793
-1,808
| -12% | -$12K | ﹤0.01% | 6015 |
|
|
2022
Q3 | $202K | Sell |
15,601
-1,991
| -11% | -$25.8K | ﹤0.01% | 5723 |
|
|
2022
Q2 | $264K | Buy |
17,592
+5,245
| +42% | +$78.7K | ﹤0.01% | 5754 |
|
|
2022
Q1 | $459K | Sell |
12,347
-3,964
| -24% | -$147K | ﹤0.01% | 5456 |
|
|
2021
Q4 | $936K | Buy |
16,311
+7,063
| +76% | +$405K | ﹤0.01% | 5119 |
|
|
2021
Q3 | $945K | Sell |
9,248
-41,741
| -82% | -$4.27M | ﹤0.01% | 5081 |
|
|
2021
Q2 | $4.98M | Buy |
50,989
+1,083
| +2% | +$106K | ﹤0.01% | 3781 |
|
|
2021
Q1 | $5.09M | Buy |
49,906
+26,255
| +111% | +$2.68M | ﹤0.01% | 3393 |
|
|
2020
Q4 | $2.33M | Buy |
23,651
+20,262
| +598% | +$1.99M | ﹤0.01% | 4025 |
|
|
2020
Q3 | $1.63M | Sell |
3,389
-144
| -4% | -$69.3K | ﹤0.01% | 3836 |
|
|
2020
Q2 | $2.74M | Buy |
3,533
+3,508
| +14,032% | +$2.72M | ﹤0.01% | 3286 |
|
|
2020
Q1 | $17K | Sell |
25
-645
| -96% | -$439K | ﹤0.01% | 5860 |
|
|
2019
Q4 | $615K | Buy |
+670
| New | +$615K | ﹤0.01% | 4813 |
|